Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

VYNE Therapeutics (VYNE) Interest & Investment Income (2016 - 2018)

VYNE Therapeutics' Interest & Investment Income history spans 3 years, with the latest figure at $826000.0 for Q2 2018.

  • For Q2 2018, Interest & Investment Income rose 1047.22% year-over-year to $826000.0; the TTM value through Jun 2018 reached $1.8 million, changed N/A, while the annual FY2017 figure was $517000.0, 95.83% up from the prior year.
  • Interest & Investment Income reached $826000.0 in Q2 2018 per VYNE's latest filing, up from $563000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $826000.0 in Q2 2018 to a low of $72000.0 in Q2 2017.
  • Average Interest & Investment Income over 3 years is $284714.3, with a median of $163000.0 recorded in 2017.
  • Peak YoY movement for Interest & Investment Income: soared 127.27% in 2017, then soared 1047.22% in 2018.
  • A 3-year view of Interest & Investment Income shows it stood at $88000.0 in 2016, then skyrocketed by 127.27% to $200000.0 in 2017, then soared by 313.0% to $826000.0 in 2018.
  • Per Business Quant, the three most recent readings for VYNE's Interest & Investment Income are $826000.0 (Q2 2018), $563000.0 (Q1 2018), and $200000.0 (Q4 2017).